World Health Organization · 1st edition, 2025 · 44 pages
WHO normative guidance standardizing NTD data collection, quality assessment, and reporting through national health information systems.
- Issuer
- World Health Organization
- Edition
- 1st edition, 2025
- Audience
- National NTD programme managers, health information system managers, district health officers, data clerks, health facility staff, partner organizations supporting NTD programmes
- Evidence
- Normative guidance developed through WHO expert consultation, steering committee with regional representatives, and review by national programme managers
- Reviewed
- 15 Oct 2026 · GMJ
What this guideline says
GMJ summary
This WHO normative guidance establishes standards for integrating neglected tropical disease (NTD) data into national routine health information systems (RHIS). Covering 21 NTDs including Buruli ulcer, Chagas disease, dengue, dracunculiasis, leishmaniasis, leprosy, lymphatic filariasis, rabies, schistosomiasis, soil-transmitted helminthiases, trachoma, and yaws, the document provides harmonized core indicators, case definitions, and data quality metrics for health facility-based and community-based interventions.
The guidance promotes mainstreaming NTD data into existing national health information systems rather than maintaining parallel vertical systems. It defines key programme indicators across five core NTD interventions: preventive chemotherapy (with targets such as 75% coverage for schistosomiasis and soil-transmitted helminthiases, 65% for lymphatic filariasis and onchocerciasis, 80% for trachoma, 90% for yaws), case management, veterinary public health, vector control, and WASH. Data quality assessment standards include completeness (≥90% of monthly facility reports received), timeliness (≥75% submitted on deadline), and internal and external consistency checks.
The document forms part of the WHO RHIS toolkit and supports the road map for neglected tropical diseases 2021–2030. It includes standardized case definitions (suspected, probable, confirmed) for all 21 NTDs, disaggregation requirements by age, sex, administrative unit, and disease characteristics, and guidance on using data for monitoring progress toward control, elimination, or eradication targets. A companion compendium provides detailed indicator metadata.
Key points
For clinicians — doses and thresholds as stated in the guideline
- Preventive chemotherapy minimum effective coverage targets: 75% for schistosomiasis and soil-transmitted helminthiases; 65% for lymphatic filariasis; 65% (rising to 80%) for onchocerciasis; 80% for trachoma; 90% for yaws; 75% for foodborne trematodiases; 70% for taeniasis.
- Data quality benchmarks: ≥90% of expected monthly health facility reports received; ≥75% of reports submitted on time; districts with <90% non-zero values flagged for review.
- All NTD cases disaggregated by age groups: <1 year, 1–4 years, 5–14 years, 15–24 years, 25–49 years, 50–64 years, ≥65 years; by sex (male/female); and by case classification (suspected, probable, confirmed).
- Dracunculiasis and yaws rumours must be investigated within 24 hours in areas targeted for eradication.
- Case definitions standardized across three levels: suspected (clinical criteria), probable (clinical + epidemiological or presumptive lab), confirmed (laboratory-confirmed or specific diagnostic criteria).
- Vector control coverage measured as proportion of households receiving integrated vector management activities and proportion of population at risk protected annually.
- Rabies and snakebite envenoming require reporting: number of people bitten by animals, deaths within 3 months of bite, and people receiving post-exposure prophylaxis or antivenom.
- Logistics indicators tracked monthly: opening stock, products received, products consumed, days stocked out, and products expired by NTD medical product type.
Standard metrics for periodic assessment of data quality for NTD programmes
Table extracted from the guideline
| Data quality metric | National level | Subnational level |
|---|---|---|
| Completeness of health facility reporting | % of expected facility monthly reports for previous one year that are actually received | Number and % of districts with at least 90% of monthly facility reports received |
| Timeliness of health facility | % of submitted facility monthly reports for the previous one year that are received on time | Number and % of districts with at least 75% of monthly facility reports received |
| Completeness of district reporting | % of expected district monthly reports that actually received | Number and % of districts that submitted 100% of expected monthly reports |
| Timeliness of district reporting | % of submitted district monthly reports for previous one year that are received on time | Number and % of districts that submitted on time at least 75% of monthly reports received at national level from district |
| Completeness of indicator data | % of data elements that are non-zero values, % of data elements that are non-missing values | Number and % of districts with <90% non-zero values; non-missing values |
| Consistency of reporting of completeness | Evaluate the trend in completeness of reporting from district to national over the past 3 years | Evaluate the trend in completeness of reporting from health facility to district over the past 3 years |
Source: World Health Organization, Routine health information system and health facility data for neglected tropical diseases: general guidance for national programme managers and data clerks. Reproduced in summary form.
From the guideline
Verbatim
“NTD programmes are strongly encouraged to mainstream NTD data collection, storage, analysis and reporting into national health information systems.”
Editor’s perspective
Why this matters for Georgia and the region
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, Public Health Institute of Georgia · WHO consultant, health and migration
As WHO consultant and public health leader in the Caucasus, I recognize this guidance addresses a critical gap in our regional surveillance architecture. Georgia's digitalized health system, built since our UHC reforms in 2013, provides an excellent platform for integrating NTD data—particularly for echinococcosis in pastoral regions, cutaneous leishmaniasis in eastern Georgia, and cross-border rabies surveillance. I would stress to Georgian colleagues the importance of the 24-hour investigation requirement for any rumoured dracunculiasis or yaws cases, even though these are not currently endemic; our proximity to endemic regions and population movements demand vigilance. The practical challenge will be training primary care physicians and paramedics to recognize the clinical presentations in the standardized case definitions—many of these conditions are rare enough that frontline providers lack diagnostic familiarity, yet early detection is essential for elimination targets. The data quality metrics provide objective benchmarks we can incorporate into our existing health facility performance monitoring.
ORCID 0000-0001-7609-4515 · Perspective written for the GMJ Guidelines Library, 15 Oct 2026
Applicability
Georgia and the South Caucasus
Georgia has made significant progress in health information system strengthening as part of its universal health coverage programme since 2013 and European health system alignment efforts. This guidance is directly applicable to Georgian NTD surveillance, particularly for leishmaniasis (cutaneous and visceral), echinococcosis, rabies, and soil-transmitted helminthiases documented in the country. The Caucasus region experiences cross-border transmission of several vector-borne NTDs, making standardized surveillance critical for regional cooperation with Armenia, Azerbaijan, Turkey, and Russia. National programmes should assess current NTD data flows—many likely operating as vertical systems separate from the national electronic health record—and develop a phased integration plan. The guidance’s emphasis on mainstreaming into existing RHIS aligns with Georgia’s digitalized health infrastructure, though translation of case definitions and indicator metadata into Georgian and tailoring age categories to match national demographic reporting standards will be necessary for implementation.
Questions this guideline answers
Quick answers
What is the difference between suspected, probable, and confirmed NTD cases?
Suspected cases meet clinical criteria without laboratory confirmation. Probable cases meet clinical criteria plus have presumptive laboratory results or epidemiological linkage to other cases. Confirmed cases are laboratory-confirmed or meet specific diagnostic criteria (e.g., visualization of worms, positive PCR, characteristic imaging findings). Case definitions vary by disease and are detailed in the document annex.
What coverage levels are needed for preventive chemotherapy campaigns?
Minimum effective coverage targets vary by disease: 75% for schistosomiasis, soil-transmitted helminthiases, and foodborne trematodiases; 65% for lymphatic filariasis; 65–80% for onchocerciasis; 80% for trachoma; 90% for yaws; and 70% for taeniasis. These represent the proportion of the target population that must receive treatment to achieve public health impact.
How should NTD programmes assess data quality?
Use four standard metrics: completeness (≥90% of expected reports received), timeliness (≥75% submitted on deadline), internal consistency (checking for outliers, repeated values, alignment between related indicators), and external consistency (comparing routine data against surveys or other sources). Population denominator consistency should also be verified across different data sources.
Should NTD data be managed in separate disease-specific systems?
No. The guidance strongly recommends mainstreaming NTD data into existing national health information systems rather than maintaining parallel vertical systems. This increases sustainability, reduces administrative burden, enables NTD programmes to benefit from broader health information system investments, and ensures NTD data contribute to universal health coverage and Sustainable Development Goal monitoring.
Related on GMJ
Interconnected resources
Dictionary of Public Health
Conditions A–Z
GMJ News coverage
- Buruli ulcer in Africa: balancing innovation with pragmatic care deliveryAug 2026
- Multi-country study reveals critical gaps in Chagas disease data systems across Bolivia and ParaguayJun 2026
- Sri Lanka deploys military to combat surging dengue epidemic as hospitals reach capacityAug 2026
- Tropical Cyclones Dramatically Amplify Dengue Transmission, Study FindsJul 2026
Quality & accreditation
Other guidelines on this topic
- Routine health information system and health facility and community data for neglected tropical diseases: last-mile logistics information system for medicines and health products
- Routine health information system and health facility data for neglected tropical diseases: Buruli ulcer
- Anthrax: implementation guidance for clinicians
- Routine health information system and health facility data for neglected tropical diseases: Schistosomiasis
- Standard case definitions of acute bacterial meningitis and invasive meningococcal disease for routine and outbreak surveillance
- Issuer
- World Health Organization
- Type
- Guidance (normative)
- Edition
- 1st edition, 2025
- Status
- Current
- Published
- 2025-07-21
- Languages
- English
- Scope
- Global: all WHO Member States with endemic neglected tropical diseases
- Audience
- National NTD programme managers, health information system managers, district health officers, data clerks, health facility staff, partner organizations supporting NTD programmes
- Pages
- 44
- Licence
- CC BY-NC-SA 3.0 IGO
- ISBN
- 978-92-4-010707-6
- Evidence
- Normative guidance developed through WHO expert consultation, steering committee with regional representatives, and review by national programme managers
- Record history
- Created 15 Oct 2026 · updated 15 Oct 2026 · next check Apr 2027
World Health Organization. Routine health information system and health facility data for neglected tropical diseases: general guidance for national programme managers and data clerks. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.GMJ Guidelines Library records are original summaries written by the GMJ editorial team from the issuer’s published document and reviewed by a physician. They do not replace the full guideline. The document is the copyright of its issuer and is linked, not hosted. Spotted an error or a newer edition? Tell the Guidelines Desk.
Was this article helpful?

